Based in Newcastle upon Tyne, UK
Founded in 2015 with academics from Newcastle University
Strong links with global Pharmaceutical and Biotech companies and academic centres of excellence
State of the art facilities located in The Helix science campus
Fast growing company – growing to 100 employees by 2025
£10M raised since its inception, £7M equity and £3M non-dilutive

Solutions
Best in class in vitro models for accurate predictions of in vivo outcomes

Most physiologically relevant in vitro models
More predictive models for better in vivo outcomes, outperforming other existing in vitro models
Recapitulates the complexity and architecture of human tissues
Enables cross-species comparative studies
Ideal for human diseases where no other models are available (e.g., retina)
More suited to High Throughput screening than other models currently available
More cost effective than other models currently available

Model Applications

Newcells Retinal Organoids with our Associate Scientist Hannah Steward - Video